Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Oxapium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 12/20 | 0.43 |
| ▸ | CHRM3 known ✓ | P20309 | 12/20 | 0.43 |
| ▸ | CTDSP1 | Q9GZU7 | 4/20 | 0.49 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.49 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.44 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | CHRM2 | P08172 | 12/20 | 0.43 |
| ▸ | CHRM4 | P08173 | 12/20 | 0.43 |
| ▸ | CHRM5 | P08912 | 12/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxapium SCHEMBL24857 | 0.99 | CTDSP1 (0.47) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL27721335 | 0.78 | GRIN1 (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL11259848 | 0.74 | HTR1A (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| Hydrochloric Acid SCHEMBL29449197 | 0.73 | HTR1A (0.48) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL14039627 | 0.72 | CHRM2 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10807843 | 0.71 | GAA (0.49) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL10807846 | 0.69 | CHRM2 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL19420724 | 0.65 | CTDSP1 (0.97) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| SCHEMBL19420729 | 0.65 | CTDSP1 (0.97) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A | |
| Iodide SCHEMBL11127723 | 0.63 | APOBEC3A (0.61) | CTDSP1PABPC1APOBEC3AAPOBEC3GKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 206 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107082517-B | Water treatment system for phased array focusing ultrasonic hysteromyoma treatment system | 中惠医疗科技（上海）有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-112698608-B | Timer switch data acquisition system | 宁波恒达高智能科技股份有限公司 | 2022-09-30 | — | — | CN | claimed |
| CN-106560470-B | A kind of preparation method of Oxapium Iodide | 平光制药股份有限公司 | 2019-01-25 | — | — | CN | claimed |
| CN-106560469-A | High-yield oxapium iodide preparation method | 平光制药股份有限公司 | 2017-04-12 | — | — | CN | claimed |
| CN-106560470-A | Oxapium iodide preparation method | 平光制药股份有限公司 | 2017-04-12 | — | — | CN | claimed |
| CN-102138900-B | Solid preparation of oxapium iodide liposome | HAINAN LINGKANG PHARMACEUTICAL | 2012-11-21 | — | — | CN | claimed |
| CN-102138900-A | Solid preparation of oxapium iodide liposome | HAINAN LINGKANG PHARMACEUTICAL | 2011-08-03 | — | — | CN | claimed |
| CN-101926781-A | Solid medicinal composition of oxapium iodide | BEIJING DVENTUREPHARM TECHNOLOGY DEV CO LTD | 2010-12-29 | — | — | CN | claimed |
| CN-101121708-B | Method for synthesizing oxapium iodide and analogue thereof | XIAOXIANG LI | 2010-12-15 | — | — | CN | claimed |
| CN-101121708-A | Method for synthesizing oxapium iodide and analogue thereof | XIAOXIANG LI (CN) | 2008-02-13 | — | — | CN | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| JP-58026879-A | — | — | None | — | — | JP | disclosed |
| JP-58026879-A | — | — | None | — | — | JP | disclosed |
| US-12571021-B2 | Methods for quantifying starch and cellulose in corn samples | EDENIQ, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-20250319001-A1 | OIL FOR COSMETIC AND COSMETIC CONTAINING SAME | NOF CORPORATION (JP) | 2025-10-16 | — | — | US | disclosed |
| US-5130126-A | Medicine polyoxyalkylene-addition copolymer for sustained release | NIPPON OIL & FATS CO., LTD. (JP) | 1992-07-14 | — | — | US | disclosed |
| EP-0452179-A2 | Polymer-combined drug for gastric treatment and a method for producing the drug | NIPPON OIL AND FATS COMPANY, LIMITED (JP) | 1991-10-16 | — | — | EP | disclosed |
| US-4457931-A | ANTISPASMODIC | SELVI & C. S.P.A. (IT) | 1984-07-03 | — | — | US | disclosed |
| JP-S5826879-A | SEPARATION OF STERIC ISOMER OF 1-((2-CYCLOHEXYL-2-PHENYL 1,3-DIOXOLAN-4-YL)METHYL)-1-METHYLPIPERIDINIUM IODIDE | FUJIREBIO INC | 1983-02-17 | — | — | JP | disclosed |
| JP-S5826879-A | SEPARATION OF STERIC ISOMER OF 1-((2-CYCLOHEXYL-2-PHENYL 1,3-DIOXOLAN-4-YL)METHYL)-1-METHYLPIPERIDINIUM IODIDE | FUJIREBIO INC | 1983-02-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12571021-B2 | Methods for quantifying starch and cellulose in corn samples | TREH, TALDO1, CEL | CHRM1 2157/4885CHRM3 3813/4885CTDSP1 2472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.